Diagnosis and management of prosthetic joint infection

Current Opinion in Infectious Diseases

Volumn 25, Issue 6, 2012, Pages 670-676

  Peel, Trisha N ^a,b   Buising, Kirsty L ^b   Choong, Peter F M ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

biofilm; diagnosis; prosthetic joint infection; treatment approaches

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; DAPTOMYCIN; FLUORODEOXYGLUCOSE F 18; FUSIDIC ACID; LINEZOLID; MINOCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN;

ANTIMICROBIAL THERAPY; ARTHROPLASTY; BIOFILM; ENTEROCOCCUS FAECALIS; GRAM NEGATIVE INFECTION; IMMUNE RESPONSE; PATHOGENESIS; PERIPROSTHETIC JOINT INFECTION; POSITRON EMISSION TOMOGRAPHY; PROPIONIBACTERIUM ACNES; QUALITY OF LIFE; REVIEW; STAPHYLOCOCCUS; ULTRASOUND;

ANTI-INFECTIVE AGENTS; HUMANS; OSTEOARTHRITIS; PROSTHESIS-RELATED INFECTIONS; SURGICAL PROCEDURES, OPERATIVE;

EID: 84870066102     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32835915db     Document Type: Review

References (63)

1. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89:780-785. (Pubitemid 46564282)
2. Kurtz SM, Ong KL, Lau E, et al. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468:52-56.
3. Ong KL, Kurtz SM, Lau E, et al. Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. J Arthroplasty 2009; 24 (6 SUPPL. 6): 105-109.
4. Kurtz SM, Lau E, Watson H, et al. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012 [Epub ahead of print].
5. Peel TN, Dowsey MM, Buising KL, et al. Cost analysis of debridement and retention for management of prosthetic joint infection. Clin Microbiol Infect 2011 [Epub ahead of print].
6. Bozic KJ, Ries MD. The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 2005; 87:1746-1751. (Pubitemid 41061193)
7. Zimmerli W, Trampuz A,Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351:1645-1654.
8. Costerton JW. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-1322. (Pubitemid 29289651)
9. Peel TN, Cheng AC, Buising KL, Choong PF. The microbiological aetiology, epidemiology and clinical profile of prosthetic joint infections: are current antibiotic prophylaxis guidelines effective? Antimicrob Agents Chemother 2012; 56:2386-2391.
10. Piper KE, Jacobson MJ, Cofield RH, et al. Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol 2009; 47:1878-1884.
11. Zeller V, Ghorbani A, Strady C, et al. Propionibacterium acnes: an agent of prosthetic joint infection and colonization. J Infect 2007; 55:119-124. (Pubitemid 47029748)
12. Murdoch DR, Roberts SA, Fowler VG, et al. Infection of orthopedic prostheses after Staphylococcus aureus bacteremia. Clin Infect Dis 2001; 32:647-649. (Pubitemid 32565009)
13. Trampuz A, Zimmerli W. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr Infect Dis Rep 2008; 10:394-403.
14. Atkins BL, Athanasou N, Deeks JJ, et al. Prospective evaluation of criteria for microbiological diagnosis of prosthetic-joint infection at revision arthroplasty. J Clin Microbiol 1998; 36:2932-2939. (Pubitemid 28429417)
15. Parvizi J, Zmistowski B, Berbari E, et al. New definition for periprosthetic joint infection: from the workgroup of the musculoskeletal infection society. Clin Orthop Relat Res 2011; 469:2992-2994. Musculoskeletal Infection Society (MSIS) workgroup recommendations for a new definition of PJ.I.
16. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 2007; 357:654-663. (Pubitemid 47267235)
17. Mirra JM, Amstutz HC,Matos M,Gold R. The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop Relat Res 1976; 117:221-240.
18. Esposito S, Leone S, Bassetti M, et al. Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults. Infection 2009; 37:478-496.
19. AAOS. The diagnosis of periprosthetic joint infections of the hip and knee -guideline and evidence report 2010. www.aaos.org/research/guidelines/ PJIguideline. pdf. [Accessed 30 June 2012] American Academy of Orthopaedic Surgeons guidelines for the diagnosis of periprosthetic joint infections including diagnostic algorithms.
20. Matthews PC, Berendt AR, McNally MA, Byren I. Diagnosis and management of prosthetic joint infection. Br Med J 2009; 338:1378-1383.
21. Marculescu CE, Berbari EF, Hanssen AD, et al. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42:471-478. (Pubitemid 43202518)
22. Schafer P, Fink B, Sandow D, et al. Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy. Clin Infect Dis 2008; 47:1403-1409.
23. Berbari E, Mabry T, Tsaras G, et al. Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 2010; 92:2102-2109.
24. Topolski MS, Chin PYK, Sperling JW, Cofield RH. Revision shoulder arthroplasty with positive intraoperative cultures: the value of preoperative studies and intraoperative histology. J Shoulder Elbow Surg 2002; 15:402-406. (Pubitemid 44016085)
25. Bottner F, Wegner A, Winkelmann W, et al. Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Am 2007; 89:94-99.
26. Trampuz A, Hanssen AD, Osmon DR, et al. Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med 2004; 117:556-562. (Pubitemid 39304205)
27. Parvizi J, McKenzie JC, Cashman JP. Diagnosis of periprosthetic joint infection using synovial c-reactive protein. J Arthroplasty 2012 [Epub ahead of print].
28. Parvizi J, Jacovides C, Antoci V, Ghanem E. Diagnosis of periprosthetic joint infection: the utility of a simple yet unappreciated enzyme. J Bone Joint Surg Am 2011; 93:2242-2248. A prospective study involving 108 patients assessing the utility of assessing for leucocyte esterase to diagnose PJ.I.
29. Wetters NG, Berend KR, Lombardi AV, et al. Leukocyte esterase reagent strips for the rapid diagnosis of periprosthetic joint infection. J Arthroplasty 2012 [Epub ahead of print].
30. De Man FHR, Graber P, Luem M, et al. Broad-range PCR in selected episodes of prosthetic joint infection. Infection 2009; 37:292-294.
31. Moojen DJF, Spijkers SNM, Schot CS, et al. Identification of orthopaedic infections using broad-range polymerase chain reaction and reverse line blot hybridization. J Bone Joint Surg Am 2007; 89:1298-1305. (Pubitemid 46898002)
32. Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprosthetic infection. J Bone Joint Surg Am 2006; 88:869-882.
33. Krimmer V, Merkert H, von Eiff C, et al. Detection of Staphylococcus aureus and Staphylococcus epidermidis in clinical samples by 16S rRNA-directed in site hybridization. J Clin Microbiol 1999; 37:2667-2673. (Pubitemid 29337296)
34. Achermann Y, Vogt M, Leunig M, et al. Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants. J Clin Microbiol 2010; 48:1208-1214.
35. Harris LG, El-Bouri K, Johnston S, et al. Rapid identification of staphylococci from prosthetic joint infections using MALDI-TOF mass-spectrometry. Int J Artif Organs 2010; 33:568-574.
36. Nagoya S, Kaya M, Sasaki M, et al. Diagnosis of peri-prosthetic infection at the hip using triple-phase bone scintigraphy. J Bone Joint Surg Am 2008; 90:140-144. (Pubitemid 351303336)
37. Palestro CJ, Love C, Miller TT. Infection and musculoskeletal conditions: imaging of musculoskeletal infections. Best Pract Res Clin Rheumatol 2006; 20:1197-1218.
38. Kwee TC, Kwee RM, Alavi A. FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis. Eur J Nucl Med Mol Imaging 2008; 35:2122-2132.
39. Cyteval C, Hamm V, Sarrabere MP, et al. Painful infection at the site of hip prosthesis: CT imaging. Radiology 2002; 224:477-483. (Pubitemid 34809130)
40. Achermann Y, Clauss M, Derksen L, et al. Risk factors for rifampin resistance of staphylococci causing periprosthetic joint infections S 7.4. 29th Annual Meeting of the European Bone and Joint Infection Society; 2-4 September 2010; Heidelberg, Germany.
41. Garcia-Oltra E, Garcia-Ramiro S, Martinez JC, et al. Prosthetic joint infection by Candida spp. Rev Esp Quimioter 2011; 24:37-41. A retrospective review of treatment and outcomes of 10 patients with candidal PJI reporting a high rate of failure.
42. Steckelberg JM, Osmon DR. Prosthetic joint infections. In: Waldvogel FA, Bisno AL, editors. Infections associated with indwelling medical devices. 3rd ed. Washington, DC: ASM Press; 2000. pp. 173-209.
43. Langlais F. Can we improve the results of revision arthroplasty for infected total hip replacement? J Bone Joint Surg Am 2003; 85:637-640. (Pubitemid 36927023)
44. Engesaeter LB, Dale H, Schrama JC, et al. Surgical procedures in the treatment of 784 infected THAs reported to the Norwegian Arthroplasty Register. Acta Orthop 2011; 82:530-537. A study from the Norwegian Arthroplasty Register describing the treatment and outcomes of 784 prosthetic hip infections following 124 759 total hip arthroplasty (THA). Two-stage exchange was the most common treatment strategy, with the best outcomes compared with one-stage exchange and debridement and retention.
45. Beswick AD, Elvers KT, Smith AJ, et al. What is the evidence base to guide surgical treatment of infected hip prostheses? Systematic review of longitudinal studies in unselected patients. BMC Med 2012; 10:18. A systematic review of 62 studies comparing outcomes of one-stage and twostage exchange.
46. Brandt CM, Sistrunk WW, Duffy MC, et al. Staphylococcus aureus prosthetic joint infection treated with debridement and prosthesis retention. Clin Infect Dis 1997; 24:914-919. (Pubitemid 27193877)
47. Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic kneeassociated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12:433-439.
48. Widmer AF, Frei R, Rajacic Z, Zimmerli W. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162:96-102. (Pubitemid 20223955)
49. Widmer AF, Wiestner A, Frei R, Zimmerli W. Killing of nongrowing and adherent Escherichia coli determines drug efficacy in device-related infections. Antimicrob Agents Chemother 1991; 35:741-746.
50. Senneville E, Joulie D, Legout L, et al. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 2011; 53:334-340. A retrospective cohort study examining the outcome of patients with S. aureus PJIs.
51. Forrest GN, Tamura K. Rifampin combination therapy for nonmycobacterial infections. Clin Microbiol Rev 2010; 23:14-34.
52. Nimmo GR, Pearson JC, Collignon PJ, et al. Prevalence of MRSA among Staphylococcus aureus isolated from hospital inpatients, 2005: report from the Australian Group for Antimicrobial Resistance. Commun Dis Intell 2007; 31:288-296.
53. Aboltins CA, Page MA, Buising KL, et al. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin Microbiol Infect 2007; 13:586-591. (Pubitemid 46730664)
54. Segreti J, Nelson JA, Trenholme GM. Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 1998; 27:711-713. (Pubitemid 29244322)
55. Soriano A, Gomez J, Gomez L, et al. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. Eur J Clin Microbiol Infect Dis 2007; 26:353-356. (Pubitemid 46716796)
56. Rao N, Regalla DM. Uncertain efficacy of daptomycin for prosthetic joint infections. Clin Orthop Relat Res 2006; 451:34-37. (Pubitemid 44511305)
57. John A-K, Baldoni D, Haschke M, et al. Efficacy of daptomycin in implantassociated infection due to methicillin-resistant Staphylococcus aureus: importance of combination with rifampin. Antimicrob Agents Chemother 2009; 53:2719-2724.
58. Tafin UF, Corvec S, Betrisey B, et al. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012; 56:1885-1891. A foreign-body infection model examining the efficacy of different antibiotics against P. acnes.
59. Holmberg A, Morgelin M, Rasmussen M. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms. J Antimicrob Chemother 2012; 67:433-439. In-vitro E. faecalis biofilm model demonstrating efficacy with linezoli and ciprofloxacin combinations.
60. Hsieh P-H, Lee MS, Hsu K-Y, et al. Gram-negative prosthetic joint infections: risk factors and outcome of treatment. Clin Infect Dis 2009; 49:1036-1043.
61. Aboltins CA, Dowsey MM, Buising KL, et al. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin Microbiol Infect 2011; 17:862-867.
62. McDonald DJ, Fitzgerald RH, Ilstrup DM. Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg Am 1989; 71:828-834. (Pubitemid 19205262)
63. Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Antimicrob Agents Chemother 2011; 55:3591-3593. An in-vitro candidal biofilm model demonstrating that activity against biofilm dwelling Candida was best preserved for caspofungin.